These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32377219)

  • 1. Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Nutr Metab (Lond); 2020; 17():34. PubMed ID: 32377219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis
    Li H; Xi Y; Liu H; Xin X
    Front Nutr; 2022; 9():914079. PubMed ID: 36091227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of obeticholic acid and simvastatin protects against high-fat diet-induced non-alcoholic steatohepatitis in mice.
    Li WC; Zhao SX; Ren WG; Zhang YG; Wang RQ; Kong LB; Zhang QS; Nan YM
    Exp Ther Med; 2021 Aug; 22(2):830. PubMed ID: 34149876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Yamauchi N; Ushiku T; Moriya K; Yotsuyanagi H; Koike K
    PLoS One; 2020; 15(8):e0234750. PubMed ID: 32785220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
    Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
    Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver lipidomics analysis reveals the anti-obesity and lipid-lowering effects of gypnosides from heat-processed Gynostemma pentaphyllum in high-fat diet fed mice.
    Xie P; Xie JB; Xiao MY; Guo M; Qi YS; Li FF; Piao XL
    Phytomedicine; 2023 Jul; 115():154834. PubMed ID: 37094422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gypenosides Altered Hepatic Bile Acids Homeostasis in Mice Treated with High Fat Diet.
    Lu Y; Du Y; Qin L; Wu D; Wang W; Ling L; Ma F; Ling H; Yang L; Wang C; Wang Z; Zhou X; He Y
    Evid Based Complement Alternat Med; 2018; 2018():8098059. PubMed ID: 30105069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of heat-processed Gynostemma pentaphyllum on high-fat diet-fed mice of obesity and functional analysis on network pharmacology and molecular docking strategy.
    Xie P; Guo M; Xie JB; Xiao MY; Qi YS; Duan Y; Li FF; Piao XL
    J Ethnopharmacol; 2022 Aug; 294():115335. PubMed ID: 35513215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
    Mudaliar S; Henry RR; Sanyal AJ; Morrow L; Marschall HU; Kipnes M; Adorini L; Sciacca CI; Clopton P; Castelloe E; Dillon P; Pruzanski M; Shapiro D
    Gastroenterology; 2013 Sep; 145(3):574-82.e1. PubMed ID: 23727264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
    J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling.
    Sheng D; Zhao S; Gao L; Zheng H; Liu W; Hou J; Jin Y; Ye F; Zhao Q; Li R; Zhao N; Zhang L; Han Z; Wei L
    Cell Biosci; 2019; 9():77. PubMed ID: 31548878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis
    Li H; Xi Y; Xin X; Feng Q; Hu Y
    Front Pharmacol; 2023; 14():1148737. PubMed ID: 37077819
    [No Abstract]   [Full Text] [Related]  

  • 14. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
    Shen S; Wang K; Zhi Y; Shen W; Huang L
    Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis.
    Matye DJ; Qin X; Hasan MN; Gu L; Clayton YD; Li F; Li T
    Liver Res; 2022 Dec; 6(4):276-283. PubMed ID: 36819659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
    Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH.
    Di Pasqua LG; Cagna M; Palladini G; Croce AC; Cadamuro M; Fabris L; Perlini S; Adorini L; Ferrigno A; Vairetti M
    Liver Int; 2024 Jan; 44(1):214-227. PubMed ID: 37904642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.